Literature DB >> 29091069

Phase contrast imaging of preclinical portal vein embolization with CO2 microbubbles.

Rongbiao Tang1, Fuhua Yan1, Guo Yuan Yang2, Ke Min Chen1.   

Abstract

Preoperative portal vein embolization (PVE) is employed clinically to avoid postoperative liver insufficiency. Animal models are usually used to study PVE in terms of mechanisms and pathophysiological changes. PVE is formerly monitored by conventional absorption contrast imaging (ACI) with iodine contrast agent. However, the side effects induced by iodine can give rise to animal damage and death. In this study, the feasibility of using phase contrast imaging (PCI) to show PVE using homemade CO2 microbubbles in living rats has been investigated. CO2 gas was first formed from the reaction between citric acid and sodium bicarbonate. The CO2 gas was then encapsulated by egg white to fabricate CO2 microbubbles. ACI and PCI of CO2 microbubbles were performed and compared in vitro. An additional increase in contrast was detected in PCI. PCI showed that CO2 microbubbles gradually dissolved over time, and the remaining CO2 microbubbles became larger. By PCI, the CO2 microbubbles were found to have certain stability, suggesting their potential use as embolic agents. CO2 microbubbles were injected into the main portal trunk to perform PVE in living rats. PCI exploited the differences in the refractive index and facilitated clear visualization of the PVE after the injection of CO2 microbubbles. Findings from this study suggest that homemade CO2 microbubbles-based PCI is a novel modality for preclinical PVE research.

Entities:  

Keywords:  CO2 microbubbles; phase contrast imaging; portal vein embolization

Mesh:

Substances:

Year:  2017        PMID: 29091069     DOI: 10.1107/S1600577517014072

Source DB:  PubMed          Journal:  J Synchrotron Radiat        ISSN: 0909-0495            Impact factor:   2.616


  1 in total

1.  In Vivo Contrast Imaging of Rat Heart with Carbon Dioxide Foam.

Authors:  Anton Karalko; Peter Keša; Frantisek Jelínek; Luděk Šefc; Jan Ježek; Pavel Zemánek; Tomáš Grus
Journal:  Sensors (Basel)       Date:  2022-07-08       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.